Association of EcoRI polymorphism of the metastasis-suppressor gene NME1 with susceptibility to and severity of non-small cell lung cancer

Lung Cancer

Volumn 58, Issue 2, 2007, Pages 191-195

  Hsieh, Yih Shou ^a   Lee, Yao Ling ^a   Yang, Shun Fa ^a   Yang, Jia Sin ^a   Chen, Wei ^b   Chen, Shuo Chueh ^b   Shih, Chuen Ming ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

EcoRI polymorphism; Lung cancer; Metastasis suppressor; NME1

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; CANCER GENETICS; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NME1 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

CARCINOMA, NON-SMALL-CELL LUNG; DEOXYRIBONUCLEASE ECORI; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 34848924983     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.06.008     Document Type: Article

References (33)

1. Alberg A.J., Brock M.V., and Samet J.M. Epidemiology of lung cancer: looking to the future. J Clin Oncol 23 (2005) 3175-3185
2. Chiu H.F., Cheng M.H., Tsai S.S., Wu T.N., Kuo H.W., and Yang C.Y. Outdoor air pollution and female lung cancer in Taiwan. Inhal Toxicol 18 (2006) 1025-1031
3. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics CA. Cancer J Clin 57 (2007) 43-66
4. Duarte R.L., and Paschoal M.E. Molecular markers in lung cancer: prognostic role and relationship to smoking. J Bras Pneumol 32 (2006) 56-65
5. Homaei-Shandiz F., Ghavam-Nassiri M.R., Sharifi N., Homaei-Shandiz A.H., Taghizadeh-Kermani A., Torshizi S.A., et al. Evaluation of the relationship between human epidermal growth factor receptor-2/neu (c-erbB-2) amplification and pathologic grading in patients with breast cancer. Saudi Med J 27 (2006) 1810-1814
6. Mareel M., and Madani I. Tumour-associated host cells participating at invasion and metastasis: targets for therapy?. Acta Chir Belg 106 (2006) 635-640
7. Che G., Zhou Q., Wang Y., Liu L., Qin Y., Sun Z., et al. Effect of nm23-H1 on reversing malignant phenotype on human lung cancer cell line L9981. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 22 (2005) 530-534
8. Tee Y.T., Chen G.D., Lin L.Y., Ko J.L., and Wang P.H. Nm23-H1: a metastasis-associated gene Taiwan. J Obstet Gynecol 45 (2006) 107-113
9. Tomita M., Ayabe T., Matsuzaki Y., and Onitsuka T. Expression of nm23-H1 gene product in mediastinal lymph nodes from lung cancer patients. Eur J Cardiothorac Surg 19 (2001) 904-907
10. Steeg P.S., Bevilacqua G., Pozzatti R., Liotta L.A., and Sobel M.E. Altered expression of nm23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res 48 (1988) 6550-6554
11. Steeg P.S., Bevilacqua G., Kopper L., Thorgeirsson U.P., Talmadge J.E., Liotta L.A., et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80 (1988) 200-204
12. Goncharuk V.N., del-Rosario A., Kren L., Anwar S., Sheehan C.E., Carlson J.A., et al. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer. Ann Diagn Pathol 8 (2004) 6-16
13. Gao Q.L., Ma D., Meng L., Wang S.X., Wang C.Y., Lu Y.P., et al. Association between nm23-H1 gene expression and metastasis of ovarian carcinoma. Ai Zheng 23 (2004) 650-654
14. Chagpar A., Magliocco A., Kerviche A., Tan L., Walley B., and DeCoteau J.F. The replication error phenotype is associated with the development of distant metastases in hormonally treated patients with breast carcinoma. Cancer 100 (2004) 913-919
15. Guo H.B., Liu F., Zhao J.H., and Chen H.L. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells. J Cell Biochem 79 (2000) 370-385
16. Che G., Chen J., Liu L., Wang Y., Li L., Qin Y., et al. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2 CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981. Neoplasma 53 (2006) 530-537
17. Che G.W., Zhou Q.H., Zhu W., Wang Y.P., Qin Y., Liu L.X., et al. Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1. Ai Zheng 24 (2005) 278-284
18. Volm M., Mattern J., and Koomagi R. Association between nm23-H1 expression, proliferation and apoptosis in non-small cell lung carcinomas. Clin Exp Metastasis 16 (1998) 595-602
19. Liu Y.J., Yan P.S., Li J., and Jia J.F. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer. World J Gastroenterol 11 (2005) 6601-6606
20. Yague J., Juan M., Leone A., Romero M., Cardesa A., Vives J., et al. BglII and EcoRI polymorphism of the human nm23-H1 gene (NME1). Nucleic Acids Res 19 (1991) 6663
21. The World Health Organization histological typing of lung tumours. 2nd ed. Am J Clin Pathol 1982;77:123-136.
22. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
23. Steeg P.S., Ouatas T., Halverson D., Palmieri D., and Salerno M. Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer 4 (2003) 51-62
24. Ouatas T., Salerno M., Palmieri D., and Steeg P.S. Basic and translational advances in cancer metastasis: nm23. J Bioenerg Biomembr 35 (2003) 73-79
25. Nie Q., Zhou Q.H., Zhu W., Liu L.X., Fu J.K., Li D.B., et al. nm23-H1 gene inhibits lung cancer cell invasion through down-regulation of PKC signal pathway. Zhonghua Zhong Liu Za Zhi 28 (2006) 334-336
26. Sirotkovic-Skerlev M., Krizanac S., Kapitanovic S., Husnjak K., Unusic J., and Pavelic K. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters. Exp Mol Pathol 79 (2005) 42-50
27. Muller W., Schneiders A., Hommel G., and Gabbert H.E. Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis. Cancer 83 (1998) 2481-2487
28. Iizuka N., Tangoku A., Hayashi H., Yosino S., Abe T., Morioka T., et al. The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma. Cancer Lett 138 (1999) 139-144
29. Lee C.S., Pirdas A., and Lee M.W. Immunohistochemical demonstration of the nm23-H1 gene product in human malignant melanoma and Spitz nevi. Pathology 28 (1996) 220-224
30. Seifert M., Welter C., Mehraein Y., and Seitz G. Expression of the nm23 homologues nm23-H4, nm23-H6, and nm23-H7 in human gastric and colon cancer. J Pathol 205 (2005) 623-632
31. Kodera Y., Isobe K., Yamauchi M., Kondoh K., Kimura N., Akiyama S., et al. Expression of nm23 H-1 RNA levels in human gastric cancer tissues A negative correlation with nodal metastasis. Cancer 73 (1994) 259-265
32. Rubio S.A., Martinez S.E., Corona J.S., Ruiz A.P., Rincon A.E., Lagunas I.A., et al. EcoRI polymorphism of the metastasis-suppressor gene NME1 in Mexican patients with breast cancer. Breast Cancer Res Treat 96 (2006) 159-161
33. Bafico A., Varesco L., De Benedetti L., Caligo M.A., Gismondi V., Sciallero S., et al. Genomic PCR-SSCP analysis of the metastasis-associated nm23-H1 (NME1) gene: a study on colorectal cancer. Anticancer Res 13 (1993) 2149-2154